Sponsored
    Follow Us:

Case Law Details

Case Name : GlaxoSmithKline Asia Pvt Ltd Vs Commissioner of Customs (Imports) (CESTAT Mumbai)
Appeal Number : Customs Appeal No: 85821 of 2020
Date of Judgement/Order : 14/09/2023
Related Assessment Year :
Become a Premium member to Download. If you are already a Premium member, Login here to access.
Sponsored

GlaxoSmithKline Asia Pvt Ltd Vs Commissioner of Customs (Imports) (CESTAT Mumbai)

Introduction: The Customs, Excise, and Service Tax Appellate Tribunal (CESTAT) Mumbai recently delivered a crucial decision in the case of GlaxoSmithKline Asia Pvt Ltd against the Commissioner of Customs. This case revolves around the issue of whether the findings of the Special Valuation Branch (SVB) are binding on the Commissioner of Customs. The CESTAT’s decision regarding remand and the impact on the appellant are discussed in detail in this article.

Detailed Subheading-Wise Analysis:

1. Background of the Case: The article provides an overview of the case, explaining that M/s GlaxoSmithKline Asia Pvt Ltd challenged an order of the Commissioner of Customs (Appeals), Mumbai-I. The challenge was related to a remand order issued by the Commissioner.

2. Jurisdiction and Remand: The article mentions that the primary contention in the case is related to the jurisdiction of the first appellate authority to issue a remand order. It explains that the appellant believed that the order of the original authority should not have been set aside.

Please become a Premium member. If you are already a Premium member, login here to access the full content.

Sponsored

Join Taxguru’s Network for Latest updates on Income Tax, GST, Company Law, Corporate Laws and other related subjects.

Leave a Comment

Your email address will not be published. Required fields are marked *

Sponsored
Sponsored
Search Post by Date
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031